false 0001040130 0001040130 2021-02-15 2021-02-15
    
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported): February 15, 2021
 
PetMed Express, Inc.
(Exact name of registrant as specified in its charter)
 
Florida
000-28827
65-0680967
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
 
 
420 South Congress Avenue Delray Beach, FL 33445
(Address of principal executive offices) (Zip Code)
 
 
(561) 526-4444
(Registrant’s telephone number, including area code)
 
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.001 per share
PETS
NASDAQ Global Select Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 8.01. Other Events.
 
On February 15, 2021, the Company has appointed the Company’s Corporate Controller Wendy Zalai, as the Corporate Secretary of the Company, effective February 16, 2021. Alison Berges, General Counsel and former Corporate Secretary of PetMed Express, Inc. (the “Company”), submitted her resignation on January 29, 2021 from all of her positions with the Company effective February 15, 2021, informing the Company that she is retiring.
 
SIGNATURES
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Dated: February 16, 2021
 
 
PETMED EXPRESS, INC.
 
 
 
 
By:
/s/ Bruce S. Rosenbloom
 
Name:
Bruce S. Rosenbloom
 
Title:
Chief Financial Officer
 
 
 
 
2